ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

5,508Medicare Part D Prescriptions Filled, Including Refills
$389K Total Retail Price of All Prescriptions
291 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
LEVOTHYROXINE SODIUM 182 175
SPIRIVA 181 163
HYDROCODONE-ACETAMINOPHEN 166 110 S3
AMLODIPINE BESYLATE 128 125
ATORVASTATIN CALCIUM 124 123
SINGULAIR 112 91
OMEPRAZOLE 111 101
METOPROLOL SUCCINATE 103 95
METFORMIN HCL 100 94
ATENOLOL 99 86
SIMVASTATIN 99 91
LISINOPRIL 94 91
FUROSEMIDE 89 85
ZOLPIDEM TARTRATE 89 72
ADVAIR DISKUS 86 75
POTASSIUM CHLORIDE 84 80
WARFARIN SODIUM 83 79
CARVEDILOL 79 73
PREDNISONE 76 68
HYDROCHLOROTHIAZIDE 75 72
MONTELUKAST SODIUM 70 56
CLONIDINE HCL 68 60
ALENDRONATE SODIUM 64 64
GLIPIZIDE 64 64
PROAIR HFA 63 52
GABAPENTIN 61 51
LOSARTAN POTASSIUM 60 60
PRAVASTATIN SODIUM 56 56
LOVASTATIN 55 53
CYCLOBENZAPRINE HCL 54 27 R
BENAZEPRIL HCL 53 49
ALLOPURINOL 52 52
PAROXETINE HCL 51 37
DIGOXIN 50 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.